Slovakia
Seerlinq, founded in 2022 and headquartered in Slovakia, is an innovative health-tech startup specializing in non-invasive diagnostics and disease treatment optimization. By leveraging cutting-edge artificial intelligence and machine learning, Seerlinq is reshaping the way Photoplethysmography (PPG) signals are analyzed to enhance the personalization of cardiovascular disease diagnostics and treatments.
The company stands out for its unique application of machine learning in analyzing the PPG curve, offering comprehensive evaluations of all measured parameters. In collaboration with a global network of physicians and clinical researchers, Seerlinq collects medically labeled data, enabling superior machine learning model training and validation.
Though the company has not yet received any recorded investments (last_investment: null), it presents a compelling opportunity for investors interested in transformative healthcare solutions through technology. Further investment could accelerate its mission to redefine cardiovascular diagnostics and treatments.
